Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPets at home Regulatory News (PETS)

Share Price Information for Pets at home (PETS)

Share Price is delayed by 15 minutes
Get Live Data
183.40    -2.40 (-1.29%)
Bid:
182.00
Ask:
184.10
Spread: 2.10 (1.154%)
Market Cap: £811.14m
PETS Live PriceLast checked at - London Stock Exchange

Intraday Pets at home Share Chart

Director/PDMR Shareholding

10 Jun 2016 14:04

RNS Number : 8999A
Pets At Home Group Plc
10 June 2016
 

10 June 2016

Notification of Transaction of Director/PDMRs

 

Pets at Home Group Plc

 

(the "Company")

 

Grant of Awards/Options under the Company's Long Term Incentive Plans

 

In accordance with the requirements of DTR 3.1.4R(1)(a), the Company announces that on 9 June 2016 (the "Award Date") it granted nil-cost options ("Awards") over ordinary shares of 1p each in the Company ("Shares") to a Director of the Company and Persons Discharging Managerial Responsibilities ("PDMRs") under the Company's Performance Share Plan ("PSP"), details of which are set out below:

 

 

Name of Director

Number of Shares Under Award

Ian Kellett

217,077

 

 

Name of PDMR

Number of Shares under Award

Sally Hopson

156,911

Peter Pritchard

184,828

Louise Stonier

110,704

 

In accordance with the requirements of DTR 3.1.4R(1)(a), the Company announces that on the Award Date it granted options ("Options") over Shares to a Director of the Company and PDMRs under the Company's Company Share Option Plan ("CSOP"), at an exercise price of £2.597 per Share, details of which are set out below:

 

Name of Director

Number of Shares Under Award

Ian Kellett

11,551

 

 

Name of PDMR

Number of Shares under Option

Sally Hopson

11,551

Peter Pritchard

11,551

 

 

The Awards/Options will become exercisable on the 3rd anniversary of the Award Date and remain exercisable up to and including the 10th anniversary of the Award Date to the extent that the performance targets applicable to the Awards/Options have been met. The performance targets are based on growth in the earnings per share of the Company from end of financial year 2016 to the end of financial year 2019 and total shareholder return.

 

 

As a result of the above, the Director/PDMRs holds Options/Awards over the following (aggregate) number of ordinary shares granted under the Company's various share schemes:

 

Name of Director

Number of Shares Under Award

Ian Kellett

565,499

 

 

Name of PDMR

Aggregate Number of Shares over which Awards/Options are held.

 

Sally Hopson

484,925

Peter Pritchard

563,862

Louise Stonier

273,687

 

 

The Company was notified of the grant of the Awards/Options on 9 June 2016.

 

For further information please contact:

 

Louise Stonier

Group Legal Director and Company Secretary

Pets at Home Group Plc

Tel: 0161 486 3590

 

 

About Pets at Home

Pets at Home Group Plc is the UK's leading specialist pet omnichannel retailer and services provider. Pets at Home operates from 419 superstores located across the UK. The Group operates the UK's largest small animal veterinary business with 388 practices, run principally under a Joint Venture model using the Vets4Pets and Companion Care brand names, and four veterinary specialist referral centres. Pets at Home is the UK's leading operator of pet grooming services offered through its 240 grooming salons. The Group also operates 7 specialist High Street based dog stores, called Barkers, as well as Ride-away, an equine retail business with a superstore and website. For more information visit: http://investors.petsathome.com/

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHAKKDKNBKDNAD
Date   Source Headline
27th May 20267:00 amRNSFY26 Preliminary Results
8th Apr 20261:47 pmRNSHolding(s) in Company
8th Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSFY26 pre-close statement
3rd Mar 20267:00 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTotal Voting Rights
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSQ3 FY26 Trading Statement
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSConfirmation of Board Changes
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
23rd Dec 20257:00 amRNSAppointment of CEO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.